Key Takeaways Abbott's Nutrition business rose 3.4% in Q2 2025, led by 6.6% Adult Nutrition growth.Abbott's FreeStyle Libre CGM sales topped $1.9B in Q2 2025, up 19.6% organically.In EPD, Abbott's Q2 2025 sales grew 7.7% organically, with biosimilar launches planned from 2026.Abbott (ABT) has consistently demonstrated strong growth and gained market share within its Nutrition business. Its Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose mon ...